GigaMune Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$400K
- Investors
-
9
GigaMune General Information
Description
Developer of in vivo cell therapy technologies intended to enable targeted gene delivery for treating cancer and genetic disorders. The company develops biotechnology platforms focused on delivering gene therapies directly inside the human body using engineered viral vectors, eliminating the need for complex ex vivo cell manufacturing, enabling health specialists to deliver advanced gene therapies more efficiently by enabling direct in-body treatment methods.
Contact Information
Website
www.gigamune.comCorporate Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
Corporate Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
GigaMune Timeline
GigaMune Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Grant | 01-Jan-2025 | $400K | Completed | Startup | ||
| 8. Grant | 01-Jan-2024 | Completed | Startup | |||
| 7. Grant | 01-Jan-2023 | Completed | Startup | |||
| 6. Seed Round | 01-Dec-2022 | Completed | Startup | |||
| 5. Grant | 11-Aug-2022 | Completed | Startup | |||
| 4. Grant | 01-Aug-2021 | Completed | Startup | |||
| 3. Angel (individual) | 29-Apr-2019 | Completed | Startup | |||
| 2. Grant | 11-Sep-2018 | $300K | Completed | Startup | ||
| 1. Grant | 01-Jan-2018 | $300K | Completed | Startup |
GigaMune Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
GigaMune Comparisons
Industry
Financing
Details
GigaMune Competitors (1)
One of GigaMune’s competitors is Edity Therapeutics, a Venture Capital-Backed company based in Rehovot, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Edity Therapeutics | Venture Capital-Backed | Rehovot, Israel |
GigaMune Patents
GigaMune Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4580664-A1 | Engineered enveloped vectors and methods of use thereof | Pending | 31-Aug-2022 | ||
| US-12371689-B2 | Engineered enveloped vectors and methods of use thereof | Active | 31-Aug-2022 | ||
| US-20240067958-A1 | Engineered enveloped vectors and methods of use thereof | Active | 31-Aug-2022 | ||
| US-20260139247-A1 | Engineered enveloped vectors and methods of use thereof | Pending | 31-Aug-2022 | ||
| WO-2024050450-A1 | Engineered enveloped vectors and methods of use thereof | Inactive | 31-Aug-2022 | C12N15/1082 |
GigaMune Signals
GigaMune Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bioverge | Venture Capital | Minority | ||
| Boost VC | Accelerator/Incubator | Minority | ||
| Heroic Ventures | Venture Capital | Minority | ||
| Newsight Tech Angels | Angel Group | Minority | ||
| Reinforced Ventures | Venture Capital | Minority |
GigaMune FAQs
-
When was GigaMune founded?
GigaMune was founded in 2017.
-
Where is GigaMune headquartered?
GigaMune is headquartered in San Francisco, CA.
-
What is the size of GigaMune?
GigaMune has 10 total employees.
-
What industry is GigaMune in?
GigaMune’s primary industry is Drug Delivery.
-
Is GigaMune a private or public company?
GigaMune is a Private company.
-
What is GigaMune’s current revenue?
The current revenue for GigaMune is .
-
How much funding has GigaMune raised over time?
GigaMune has raised $2.71M.
-
Who are GigaMune’s investors?
Bioverge, Boost VC, Heroic Ventures, Newsight Tech Angels, and Reinforced Ventures are 5 of 9 investors who have invested in GigaMune.
-
Who are GigaMune’s competitors?
Edity Therapeutics is a competitor of GigaMune.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process